Abstract |
As a continuous effort to develop novel antitumor agents, a new series of forty-five 2-phenol-4-aryl-6-chlorophenyl pyridine compounds were synthesized and evaluated for cytotoxicity against four different human cancer cell lines (DU145, HCT15, T47D, and HeLa), and topoisomerase I and II inhibitory activity. Several compounds (10-15, 20, 22, 24, 28, 42, and 49) displayed strong to moderate dual topoisomerase I and II inhibitory activity at 100 μM. It was observed that hydroxyl and chlorine moiety at meta or para position of phenyl ring is favorable for dual topoisomerase inhibitory activity and cytotoxicity. Most of the compounds displayed stronger cytotoxicities than those of all positive controls against the HCT15 and T47D cell lines. For investigation of the structure-activity relationships, a 3D-QSAR analysis using the method of comparative molecular field analysis (CoMFA) was performed. The generated 3D contour maps can be used for further rational design of novel terpyridine derivatives as highly selective and potent cytotoxic agents.
|
Authors | Radha Karki, Kyu-Yeon Jun, Tara Man Kadayat, Somin Shin, Til Bahadur Thapa Magar, Ganesh Bist, Aarajana Shrestha, Younghwa Na, Youngjoo Kwon, Eung-Seok Lee |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 113
Pg. 228-45
(May 04 2016)
ISSN: 1768-3254 [Electronic] France |
PMID | 26945111
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Pyridines
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- DNA Topoisomerases, Type I
- DNA Topoisomerases, Type II
|
Topics |
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- DNA Topoisomerases, Type I
(metabolism)
- DNA Topoisomerases, Type II
(metabolism)
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Humans
- Molecular Structure
- Pyridines
(chemical synthesis, chemistry, pharmacology)
- Quantitative Structure-Activity Relationship
- Topoisomerase I Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Topoisomerase II Inhibitors
(chemical synthesis, chemistry, pharmacology)
|